Basilea Pharmaceutica AG total revenue, net income and dynamics of changes in Swiss franc today
Net revenue Basilea Pharmaceutica AG is now 29 150 500 Fr. Information about net revenue is taken from open sources. The dynamics of net income of Basilea Pharmaceutica AG has changed by 0 Fr in recent years. These are the main financial indicators of Basilea Pharmaceutica AG. Graph of finance company Basilea Pharmaceutica AG. Basilea Pharmaceutica AG financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on Basilea Pharmaceutica AG net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
29 150 500 Fr
-18.112 % ↓
-12 331 500 Fr
-
30/09/2020
29 150 500 Fr
-18.112 % ↓
-12 331 500 Fr
-
30/06/2020
34 664 000 Fr
+9.72 % ↑
4 970 500 Fr
-
31/03/2020
34 664 000 Fr
+9.72 % ↑
4 970 500 Fr
-
31/12/2019
35 598 000 Fr
-
-3 495 500 Fr
-
30/09/2019
35 598 000 Fr
-
-3 495 500 Fr
-
30/06/2019
31 592 500 Fr
-
-7 715 500 Fr
-
31/03/2019
31 592 500 Fr
-
-7 715 500 Fr
-
Show:
to
Basilea Pharmaceutica AG financial report charts
The dates of the latest financial statements of Basilea Pharmaceutica AG: 31/03/2019, 30/09/2020, 31/12/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Basilea Pharmaceutica AG is available online for such a date - 31/12/2020. Gross profit Basilea Pharmaceutica AG is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Basilea Pharmaceutica AG is -3 069 500 Fr
Basilea Pharmaceutica AG quarterly report dates
Cost of revenue Basilea Pharmaceutica AG is the total cost of producing and distributing of products and services of a company. Cost of revenue Basilea Pharmaceutica AG is 32 220 000 Fr Total revenue Basilea Pharmaceutica AG refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Basilea Pharmaceutica AG is 29 150 500 Fr Operating income Basilea Pharmaceutica AG is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Basilea Pharmaceutica AG is -10 076 000 Fr
Net income Basilea Pharmaceutica AG is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Basilea Pharmaceutica AG is -12 331 500 Fr Current assets Basilea Pharmaceutica AG is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Basilea Pharmaceutica AG is 223 528 000 Fr Total assets Basilea Pharmaceutica AG refers to the total amount of assets owned by a person or entity. Total assets Basilea Pharmaceutica AG is 229 794 000 Fr
31/12/2020
30/09/2020
30/06/2020
31/03/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-3 069 500 Fr
-3 069 500 Fr
6 152 000 Fr
6 152 000 Fr
4 937 500 Fr
4 937 500 Fr
1 488 000 Fr
1 488 000 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
32 220 000 Fr
32 220 000 Fr
28 512 000 Fr
28 512 000 Fr
30 660 500 Fr
30 660 500 Fr
30 104 500 Fr
30 104 500 Fr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
29 150 500 Fr
29 150 500 Fr
34 664 000 Fr
34 664 000 Fr
35 598 000 Fr
35 598 000 Fr
31 592 500 Fr
31 592 500 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
35 598 000 Fr
35 598 000 Fr
31 592 500 Fr
31 592 500 Fr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-10 076 000 Fr
-10 076 000 Fr
-629 500 Fr
-629 500 Fr
-1 852 500 Fr
-1 852 500 Fr
-5 980 000 Fr
-5 980 000 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-12 331 500 Fr
-12 331 500 Fr
4 970 500 Fr
4 970 500 Fr
-3 495 500 Fr
-3 495 500 Fr
-7 715 500 Fr
-7 715 500 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
39 226 500 Fr
39 226 500 Fr
35 293 500 Fr
35 293 500 Fr
37 450 500 Fr
37 450 500 Fr
37 572 500 Fr
37 572 500 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
223 528 000 Fr
223 528 000 Fr
161 010 000 Fr
161 010 000 Fr
184 860 000 Fr
184 860 000 Fr
228 268 000 Fr
228 268 000 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
229 794 000 Fr
229 794 000 Fr
197 055 000 Fr
197 055 000 Fr
221 467 000 Fr
221 467 000 Fr
235 649 000 Fr
235 649 000 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
60 749 000 Fr
60 749 000 Fr
59 779 000 Fr
59 779 000 Fr
109 024 000 Fr
109 024 000 Fr
127 871 000 Fr
127 871 000 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
75 494 000 Fr
75 494 000 Fr
81 354 000 Fr
81 354 000 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
314 427 000 Fr
314 427 000 Fr
315 632 000 Fr
315 632 000 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
141.97 %
141.97 %
133.94 %
133.94 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-102 046 000 Fr
-102 046 000 Fr
-79 576 000 Fr
-79 576 000 Fr
-92 960 000 Fr
-92 960 000 Fr
-79 983 000 Fr
-79 983 000 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-9 229 000 Fr
-9 229 000 Fr
-22 689 000 Fr
-22 689 000 Fr
Last revenue report of Basilea Pharmaceutica AG was 31/12/2020. According to last financial report total revenue in Basilea Pharmaceutica AG was 29 150 500 Swiss franc and changed by -18.112% since last year. Net income in Basilea Pharmaceutica AG was -12 331 500 Fr in last quartal, net income changes to 0%.
Current cash Basilea Pharmaceutica AG - the sum of all of the cash a company has on the date of report. Current cash Basilea Pharmaceutica AG is 60 749 000 Fr
Basilea Pharmaceutica AG stocks data
BSLN.SW stock price
Basilea Pharmaceutica AG stock price today, BSLN.SW stock quote.
